CARLSBAD, CALIFORNIA–(Marketwired – Dec. 17, 2015) – Aurora Spine Corporation (TSX VENTURE:ASG) announced today that more than 1,000 ZIP® MIS Interspinous Fusion Devices have now been implanted in patients around the world undergoing spinal fixation procedures. “Surpassing 1,000 ZIP MIS Interspinous Fusion implants is a milestone achievement for Aurora Spine. The ZIP implant is rapidly becoming the new standard of care for minimally invasive posterior fusion,” said Trent Northcutt, Aurora Spine’s President and CEO.
The ZIP is Aurora Spine’s minimally invasive interspinous fixation implant family for spinal fusion and was developed as an alternative to pedicle screw fixation. The ZIP implant is designed for stabilization and load sharing in T1-S1spinal fusion procedures as an adjunct to interbody fusion, specifically for the treatment of degenerative disc disease, spondylolisthesis, trauma, and/or tumor. The proprietary ZIP ONE-STEP™ locking mechanism eliminates the use of a set screw. The ZIP product family includes the ZIP ULTRA®, the ZIP LP™ low profile and the ZIP 51™ sacral implant.
“The ZIP MIS Interspinous Fusion implant has been used in the United States, Canada, Europe and the Middle East to treat spinal disorders that have been treated in the past using mostly pedicle screw constructs,” said Laszlo Garamszegi, Chief Technology Officer. “Our R&D goal is to provide even more possibilities for simpler and less painful fusion procedures,” Garamszegi said. 
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company’s commitment to – Simplifying the Complex.